Tema肿瘤学主动型ETF CANC 深 沪
等待开盘 06-03 09:30:00 美东时间
36.3662
-0.894
-2.40%
华盛通- 最 高36.78
- 今 开36.78
- 成交量 5.90万股
- 最 低 36.195
- 昨 收 37.26
- 总市值 1.68亿
- 52周最高 39.95
- 市盈率 静 --
- 换手率 1.27%
- 52周最低 23.4704
- 委 比 -37.14%
- 总股本 463.00万
- 历史最高 39.95
- 量 比 2.56
- 振 幅 1.57%
- 历史最低 20.0759
- 每 手 1
- 风险率 4.89%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aptevo Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "PROSTATE-SPECIFIC MEMBRANE ANTIGEN BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS (FOR THE TREATMENT OF PROSTATE CANCER)".
https://patentcenter.uspto.gov/applications/16871597/ifw/docshttps://x.com/PatentGrants/status/2059725536650547305
05-28 04:14
BRIEF-Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings For Sil204 In Kras-Driven Pancreatic Cancer
BRIEF-Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings For Sil204 In Kras-Driven Pancreatic Cancer May 14 (Reuters) - Silexion Therapeutics Corp SLXN.O : SILEXION THERAPEUTICS REPORTS POSITIVE PRELIMINARY IMMUNOTHERAPY FINDINGS FOR SIL204 IN KRAS-DRIVEN PANCREATIC CANCER Sou
05-14 21:30
Transcript: Verrica Pharmaceuticals Q1 2026 Earnings Conference Call
On Tuesday, Verrica Pharmaceuticals (NASDAQ:VRCA) discussed first-quarter finan...
05-13 17:16
BRIEF-Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer
BRIEF-Sensei Biotherapeutics Doses First Patient In Phase 1B/2 Trial Of Piktor In Hr+/Her2- Advanced Breast Cancer May 5 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS DOSES FIRST PATIENT IN PHASE 1B/2 TRIAL OF PIKTOR IN HR+/HER2- ADVANCED BREAST CANCER SENSEI BIOTHERAPEUTICS
05-05 19:52
BRIEF-Spirit Airlines Begins Orderly Wind-Down Of Operations
BRIEF-Spirit Airlines Begins Orderly Wind-Down Of Operations May 2 (Reuters) - Spirit Aviation Holdings Inc FLYYQ.PK : SPIRIT AIRLINES BEGINS ORDERLY WIND-DOWN OF OPERATIONS SPIRIT AIRLINES- ALL FLIGHTS HAVE BEEN CANCELLED SPIRIT AIRLINES- RECENT MATERIAL INCREASE IN OIL PRICES AND OTHER PRESSURES O
05-02 14:27
UPDATE 10-Spirit Airlines shuts down, industry's first Iran war casualty
UPDATE 10-Spirit Airlines shuts down, industry's first Iran war casualty Spirit says oil-price jump impacted its financial outlook White House had proposed $500 million financing for 90% equity Board meeting ended with no agreement to rescue the company, source said Jet fuel price spike during Iran
05-01 23:53
BRIEF-Daiichi Sankyo Co Ltd - Ifinatamab Deruxtecan Granted Priority Review In The U.S. For Adult Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer Who Experienced Disease Progression On Or After Platinum-Based Chemotherapy
BRIEF-Daiichi Sankyo Co Ltd - Ifinatamab Deruxtecan Granted Priority Review In The U.S. For Adult Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer Who Experienced Disease Progression On Or After Platinum-Based Chemotherapy April 14 (Reuters) - Daiichi Sankyo Co Ltd 4568.T : DA
04-14 09:14
GNOM, CANC, IBB: Healthcare ETFs Build Long-Term Wealth for Investors
Healthcare is a major sector of the global economy.
04-10 21:43
BRIEF-Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering
BRIEF-Skeena Gold & Silver Announces Proposed USD$750 Million Senior Secured Notes Offering March 31 (Reuters) - Skeena Resources Ltd SKE.TO : SKEENA GOLD & SILVER ANNOUNCES PROPOSED USD$750 MILLION SENIOR SECURED NOTES OFFERING TO REFINANCE FORMER PROJECT FINANCING AND TO FUND PARTIAL BUYBACK OF EX
03-31 20:42
BRIEF-Nuvectis Pharma Announces Upcoming Presentations For Nxp900 At The 2026 American Association
BRIEF-Nuvectis Pharma Announces Upcoming Presentations For Nxp900 At The 2026 American Association March 31 (Reuters) - Nuvectis Pharma Inc NVCT.O : NUVECTIS PHARMA ANNOUNCES UPCOMING PRESENTATIONS FOR NXP900 AT THE 2026 AMERICAN ASSOCIATION FOR CANCER RESEARCH MEETING Source text: ID:nGNX2N59Kd Fur
03-31 20:31
